Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers
Clinical trial NCT00836225 · COMPLETED
Trial details
- NCT number
- NCT00836225
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-10-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.